GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenotech Laboratories Ltd (BOM:532039) » Definitions » 12-1 Month Momentum %

Zenotech Laboratories (BOM:532039) 12-1 Month Momentum % : 19.89% (As of Jun. 21, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Zenotech Laboratories 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-21), Zenotech Laboratories's 12-1 Month Momentum % is 19.89%.

The industry rank for Zenotech Laboratories's 12-1 Month Momentum % or its related term are showing as below:

BOM:532039's 12-1 Month Momentum % is ranked better than
71.01% of 1114 companies
in the Drug Manufacturers industry
Industry Median: -3.93 vs BOM:532039: 19.89

Competitive Comparison of Zenotech Laboratories's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Zenotech Laboratories's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenotech Laboratories's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenotech Laboratories's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Zenotech Laboratories's 12-1 Month Momentum % falls into.



Zenotech Laboratories  (BOM:532039) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenotech Laboratories  (BOM:532039) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Zenotech Laboratories 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Zenotech Laboratories's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenotech Laboratories (BOM:532039) Business Description

Traded in Other Exchanges
N/A
Address
Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.

Zenotech Laboratories (BOM:532039) Headlines

No Headlines